SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I/II trial to study the effectiveness of combining SU5416 and irinotecan in treating
patients who have advanced colorectal cancer. SU5416 may stop the growth of colorectal cancer
by stopping blood flow to the tumor. Drugs used in chemotherapy use different ways to stop
tumor cells from dividing so they stop growing or die